Menu
  • Join
  • Login
  • Contact
 

Search abstracts


The correlation between FGF-21 and metabolic effect in patients with bipolar disorder

  • At: 2016 FIP Congress in Buenos Aires (Argentina)
  • Type: Poster
  • By: CHANG, Hui Hua (National Cheng Kung University, Institute of Clinical Pharmacy and Pharmaceutical Sciences, Tainan, China Taiwan)
  • Co-author(s): Hui Hua Chang:Institute of Clinical Pharmacy and Pharmaceutical Sciences,National Cheng Kung University,Tainan,Taiwan, Province of China|Yung Wen Cheng:Institute of Clinical Pharmacy and Pharmaceutical Sciences,National Cheng Kung University,Tainan,Taiwan, Province of China|Po Wu Gean:Department of Pharmacology,National Cheng Kung University,Tainan,Taiwan, Province of China|Po See Chen:Department of Psychiatry,National Cheng Kung University,Tainan,Taiwan, Province of China
  • Abstract:

    Fibroblast growth factor-21 (FGF-21) is a novel endogenous regulator of glucose and lipid metabolism. Recent report indicated that FGF-21 is also a mediator of the neuroprotective effects of mood stabilizers in animal study. In addition, patients with bipolar disorder (BD) had high risk of metabolic abnormalities, but the role of FGF-21 in BD..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses